VanEck Pharmaceutical ETF Plans Quarterly Dividend of $0.62 (NASDAQ:PPH)

VanEck Pharmaceutical ETF (NASDAQ:PPH) announced a quarterly dividend on Tuesday, June 30th, NASDAQ Dividends reports. Shareholders of record on Wednesday, July 1st will be given a dividend of 0.6248 per share on Tuesday, July 7th. This represents a c) annualized dividend and a yield of 2.3%. The ex-dividend date is Wednesday, July 1st.

VanEck Pharmaceutical ETF Trading Down 1.3%

PPH stock traded down $1.40 during mid-day trading on Wednesday, reaching $107.95. 219,351 shares of the stock traded hands, compared to its average volume of 334,346. VanEck Pharmaceutical ETF has a 52-week low of $81.74 and a 52-week high of $112.58. The stock’s fifty day moving average is $103.49 and its 200-day moving average is $104.82. The company has a market cap of $1.02 billion, a P/E ratio of 20.21 and a beta of 0.47.

VanEck Pharmaceutical ETF Company Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.